300119.SZ深圳证券交易所 · 创业板 ChiNext
Tianjin Ringpu Bio-Technology 瑞普生物
Animal Health 动物保健Ⅱ
¥16.66−¥0.48 · −2.80%
Open 开盘
¥17.16
High 最高
¥17.33
Low 最低
¥16.62
Prev Close 昨收
¥17.14
Volume 成交量
363.8万股
Turnover 成交额
¥6,145.9万
Mkt Cap 总市值
¥77亿
P/E 市盈率
22.2×
Recent Activity 近期动态All Filings 全部公告 →
3 significant filings since 30 May 2026: 2 on guarantee or financial assistance and 1 on major holder buying. The latest, on 26 Aug 2026: 关于公司及子公司继续开展资产池业务并提供担保的公告. 1 unverified report logged, the latest on 22 Jun 2026.
自 30 May 2026 起有 3 份重大公告：guarantee or financial assistance 2 份、major holder buying 1 份。最新一份（26 Aug 2026）：关于公司及子公司继续开展资产池业务并提供担保的公告。记录了 1 条未经核实的报道，最新一条见于 22 Jun 2026。
16.0018.0020.0022.00
Volume 成交量
2,733.1万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Animal Health 动物保健Ⅱ · 12 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥77亿 | ¥39亿 | 2nd highest of 12 · 12 家中第 2 高 | |
| Trailing P/E 市盈率 | 22.2x | 48.6x | 3rd lowest of 9 · 9 家中第 3 低 | |
| P/B 市净率 | 1.6x | 2.1x | 4th lowest of 12 · 12 家中第 4 低 | |
| Revenue Growth 营收增速 | 0.8% | 0.0% | 6th highest of 12 · 12 家中第 6 高 | |
| Profit Growth 净利增速 | -20.4% | -36.2% | 5th highest of 12 · 12 家中第 5 高 | |
| Gross Margin 毛利率 | 39.7% | 38.8% | 6th highest of 12 · 12 家中第 6 高 | |
| Net Margin 净利率 | 12.9% | 8.3% | 5th highest of 12 · 12 家中第 5 高 | |
| Return on Equity 净资产收益率 | 4.3% | 2.3% | 4th highest of 12 · 12 家中第 4 高 | |
| Debt to Assets 资产负债率 | 34.4% | 23.4% | 4th highest of 12 · 12 家中第 4 高 | |
| Grade Score 评级得分 | 55 | 54 | 6th highest of 12 · 12 家中第 6 高 |
Statement figures are for the period to 30 Jun 2026, filed by 12 of 12 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，12 家同业中 12 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Jinyu 生物股份 | ¥125亿 | 87.2x | 2.3x | 22.1% | 14.7% | 1.9% | C |
| Tianjin Ringpu Bio-Technology 瑞普生物 | ¥77亿 | 22.2x | 1.6x | 0.8% | 12.9% | 4.3% | C |
| China Animal Husbandry 中牧股份 | ¥68亿 | 48.6x | 1.2x | 13.5% | 2.3% | 0.9% | D |
| Keqian Biology 科前生物 | ¥57亿 | 18.1x | 1.4x | -23.3% | 30.7% | 2.8% | C |
| Jinhe Biotechnology 金河生物 | ¥43亿 | 210.0x | 1.7x | 4.1% | 9.3% | 5.7% | C |
| Wuhan HVSEN Biotechnology 回盛生物 | ¥42亿 | 12.3x | 1.8x | 5.2% | 23.9% | 9.1% | C |
| Pulike 普莱柯 | ¥35亿 | 24.1x | 1.4x | -12.2% | 13.0% | 3.0% | C |
| Lifecome Biochemistry 绿康生化 | ¥35亿 | — | 49.1x | -15.7% | 2.8% | 10.9% | C |
| Shen Lian Biomedical 申联生物 | ¥34亿 | — | 2.5x | -8.1% | -18.2% | -1.4% | D |
| Winsunbio 永顺生物 | ¥18亿 | 64.0x | 2.7x | -28.1% | 7.3% | 0.9% | D |
| Drive 驱动力 | ¥11亿 | 460.9x | 4.6x | -0.8% | -1.6% | -0.2% | D |
| Dayu Biological 大禹生物 | ¥6.96亿 | — | 2.9x | 15.7% | -36.9% | -10.6% | E |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。